CTNI-17. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA

Research output: Contribution to conference › Presentation

Conference	Neuro-Oncology
Period	9/8/23 → …

Cite this

@conference{1068a5c651654965af790b1032a762f9,

title = "CTNI-17. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA",

author = "Minesh Mehta and Yazmin Odia and Matthew Hall and Doured Daghistani",

note = "Neuro-Oncology (2020) 22(Supplement_2):ii45-ii46; Neuro-Oncology ; Conference date: 08-09-2023",

year = "2020",

month = jan,

day = "1",

language = "American English",

}

TY - CONF

T1 - CTNI-17. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA

AU - Mehta, Minesh

AU - Odia, Yazmin

AU - Hall, Matthew

AU - Daghistani, Doured

N1 - Neuro-Oncology (2020) 22(Supplement_2):ii45-ii46

PY - 2020/1/1

Y1 - 2020/1/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/3937

M3 - Presentation

T2 - Neuro-Oncology

Y2 - 8 September 2023

ER -